Abbott stent products S. Supera Peripheral Stent System is indicated to improve luminal diameter in the treatment of patients with symptomatic de novo or restenotic native lesions or occlusions of the superficial femoral artery (SFA) and/or proximal popliteal artery with reference vessel diameters of 4. A patient with a XIENCE™ Stent can be scanned in an MR system under the following conditions Explore the XIENCE family of Drug-Eluting Stents (DES) with clinical outcome data and outstanding short and long term outcomes. The only BTK device that does it all: Provides We continue to drive for more with our new Epic Max aortic stented tissue valve that cardiac surgeons and patients have relied on. GRAFTMASTER Coronary Stent Graft System 2. RX Acculink carotid stent system with straight and tapered stent options features rapid delivery for single operator and high coverage to reduce embolic risk. Guide PCI Planning and Treatment Decisions With Intravascular Imaging Optical Coherence Tomography (OCT) is an intravascular imaging modality that uses near-infrared light to provide high-definition, cross-sectional and three-dimensional images of the vessel microstructure. 50 mm x Abbott provides quick and easy access to product literature, or Instructions for Use (IFU), through a searchable database of selected product manuals. Read more. ) Xact carotid stent system with Nitinol construction with unique variable cell size for increased stent coverage at lesion and minimize plaque extrusion. The information contained in this guide covers the XIENCE Family of Everolimus Eluting Coronary Stent Catalogue Numbers. cardiovascular. Apr 14, 2025 · With $19 billion in sales for 2024, Medical Devices is Abbott’s largest business segment. Xact carotid stent system with Nitinol construction with unique variable cell size for increased stent coverage at lesion and minimize plaque extrusion. Supera stent ordering information including key stent characteristics, stent technical parameters and available Supera stent diameters and lengths. XIENCE Skypoint Stent, the latest generation of XIENCE Stent, offers better expansion, excellent deliverability, and proven patient outcomes. Explore our cardiovascular product portfolio for healthcare professionals to find the right products to treat or manage your patient's ongoing care. From balloon angioplasty in the 1970s to bare-metal stents in the 1980s and drug-eluting stents in the 2000s, scientific innovations in coronary artery disease have come a long way. We are committed to advancing patient care by transforming the treatment of vascular disease FAQ About XIENCE™ Stent What about magnetic resonance imaging (MRI) safety with XIENCE™ Stents? 2 Nonclinical testing has shown that the XIENCE Skypoint™ and XIENCE Sierra™ Stents, in single and in overlapped configurations up to 91 mm and 71 mm in length respectively, are MR conditional. Abbott's Drug-Eluting Stent (DES) Xience features market-leading Everolimus for optimal endothelization rate. The Supera™ Stent has both the flexibility and the higher radial strength for treating peripheral artery disease in the proximal arteries and SFA. Important safety information for Abbott's Omnilink Elite Vascular Balloon-Expandable Stent System including indications, contraindications, and warnings. abbott View a selection of our products that over one million people use every day. abbott for more information. Ordering Information for XACT™ Carotid Stent System and XACT™ Transcarotid Stent System The XACT™ Carotid Stent System is available in multiple configurations to support both transcarotid (TCAR) and transfemoral carotid artery stenting (CAS); explore specifications and ordering details below. We recommend that you review the most current version any time a patient with an Abbott product needs an MRI. Refer to IFU for additional information. See full list on cardiovascular. XIENCE This page has information on ordering the XIENCE Skypoint Stent, plus stent and delivery system specifications, and hub improvements. Explore our cardiovascular product portfolio to find the right products and services to treat your patients or manage your patient's ongoing care. Aug 24, 2018 · With XIENCE Sierra, Abbott’s life-changing heart stent offers cardiologists a new level of care and precision. OCT provides automated, accurate measurements to help guide stent selection, placement and deployment. Abbott Vascular Product Catalog Coronary, Peripheral, Carotid, Embolic Protection, Biliary and Vessel Closure Systems products See also : Drug Eluting Stents (DES) / Bare Metal Stents (BMS) / Covered Stents / Self Expandable Stents / Balloon-Expandable Stents / Carotid stent CORONARY INTERVENTION An extensive portfolio of drug-eluting stents, bare metal stents, coronary guide wires, balloon dilatation catheters, and guiding catheters and accessories that help provide innovative, minimally invasive and cost-effective treatment of coronary artery disease. By combining innovation with trusted expertise, Abbott continues to shape the future of surgical care. Discover the precision, flexibility, and clinical results with the Absolute Pro Vascular Self-Expanding Stent System. Optimize your surgical approach with the Abbott XACT Carotid Stent System 82090-01, a 8-6mm x 40mm tapered nitinol stent designed for use in carotid artery stenosis procedures. Post-Stent Graft Placement – Precautions Care must be exercised when crossing a newly deployed stent graft with an intravascular ultrasound (IVUS) catheter, a coronary guide wire, a balloon catheter, or delivery system to avoid disrupting the stent graft geometry, apposition, and / or geometry. 1. XIENCE Sierra Drug Eluting Stent with a stent design for scaffold integrity and stent stability with significantly greater longitudinal strength than other DES. XIENCE drug-eluting stents (DES), the world's leading DES, has the lowest rates of late stent thrombosis and unparalleled performance, even in complex patients. The release of everolimus is intended to limit the overgrowth of tissue within the coronary stent. 1 Now, Abbott's Esprit™ BTK System offers a breakthrough innovation for you and your patients as the first-and-only FDA-approved drug-eluting resorbable scaffold for CLTI. Esprit™ BTK Everolimus Eluting Resorbable Scaffold Instructions for Use (IFU). 80 mm x 19 mm / Rapid-Exchange GRAFTMASTER Coronary Stent Graft System 2. Abbott has an industry-leading pipeline and a comprehensive portfolio of market-leading products for cardiac and vascular care, including products for coronary artery disease, vessel closure, endovascular disease and structural heart disease. 0 mm x 18 mm x 80 cm EA Our manuals contain instructions and information for physicians and radiologists. News and information on minimally invasive vascular disease therapies, covering peripheral vascular disease, aneurysms, stroke, hypertension, dialysis access, and venous issues. Check the regulatory status in your geography. Abbott offers a broad portfolio of innovative and minimally invasive products including guide wires, balloon dilatation catheters and stent systems for the treatment of peripheral artery disease (PAD) and other venous diseases. Apr 29, 2024 · Abbott has returned to the field of bio-absorbable, dissolving stents, and in somewhat uncharted territory. The XIENCE Family of Coronary Stents includes the following: Everolimus Eluting Coronary Stent Systems – XIENCE SkypointTM, XIENCE PROTMS, and XIENCE PROTM 48. The U. 80 mm x 26 mm / Rapid-Exchange GRAFTMASTER Coronary Stent Graft System 3. (Ex. Since 1999, Abbott carotid stents and embolic protection devices have been studied in more than 38,000 patients in 10 clinical trials worldwide. Data on file at Abbott. The company received a groundbreaking FDA approval for its latest drug-eluting scaffold RX Herculink Elite Renal and Biliary Stent System 4. Explore our product portfolio to find the right products to treat your patients or manage your patient's ongoing care. 1 OCT reduces . Explore the Abbott product portfolio to find the right cardiovascular products to treat your patients or manage your patient's ongoing care. Manuals and Technical Resources Look up product manuals and technical resources for Abbott cardiac and vascular products and technologies. Abbott, the global healthcare company, announced the launch of XIENCE Sierra™ Everolimus (drug) Eluting Coronary Stent System in India. D. The polymer used on XIENCE Stents has a long history of being used in medical products in contact with blood. Partnering with healthcare professionals helps create a healthier tomorrow. An extensive portfolio of drug-eluting stents, bare metal stents, coronary guide wires, balloon dilatation catheters, and guiding catheters and accessories that help provide innovative, minimally invasive and cost-effective treatment of coronary artery disease. Explore Abbott's Portfolio of Carotid Stents and Embolic Protection Systems. Explore Abbott's portfolio of self expanding and balloon expanding peripheral vascular stents featuring the latest in stent advancements and technology. Manuals Search Search for manuals by product name or category. 80 mm x 16 mm / Rapid-Exchange GRAFTMASTER Coronary Stent Graft System 2. Executive Vice President Lisa Earnhardt shares insights on what to expect from Medical Devices in 2025. VASCULAR Abbott is the global leader in drug eluting stents. Browse Synergy Surgical's selection of Abbott surgical products, including Balloons, Stents, Vascular Closures and more. XIENCE, MitraClip, stent, valve, etc. XIENCE Skypoint Stents provides excellent deliverability, even in complex lesions, compared to previous generations of XIENCE Stents. Oct 2, 2025 · O. XIENCE Skypoint, XIENCE Sierra and XIENCE Alpine Stent fluoropolymer supports XIENCE safety: unparalleled outcomes and low stent thrombosis, even in complex patients. 5 mm, and lesion lengths up to 140 mm. Abbott’s Supera™ Peripheral Stent, unique in its ability to flex and bend in dynamic vessel environments, offers much greater compression resistance than other standard nitinol stents. The XIENCE Family of Coronary Stents is intended for use by or under the direction of a doctor. The Absorb GT1 Bioresorbable Vascular Scaffold System (BVS), which releases Chronic Limb-Threatening Ischemia (CLTI) is a severe form of peripheral artery disease (PAD) that can lead to amputation and increased mortality/cardiovascular events. Omnilink Elite vascular balloon-expandable stent system featuring cobalt chromium multi-link technology with data on high freedom from CD-TLR at 3 years. XIENCE drug-eluting stents (DES), the world's leading DES, has the lowest rates of late stent thrombosis and unparalleled performance, even in complex patients. Learn about how the RX Herculink Stent System provides excellent strength, visibility, and deliverability to the renal arteries. Xpert Pro™ Self-Expanding Stent System is designed to deliver precise stent deployment and placement and is engineered for excellent deliverability. Engineered by Abbott, a global leader in cardiovascular innovation, this self-expanding stent features a variable cell design for targeted radial strength and plaque coverage, with flared ends for stable deployment We collaborate with scientists, health care professionals and patients to develop life-changing cardiovascular technologies. 0 to 6. This device is commercially available for use in select international markets. Visit www. Explore Abbott's portfolio to nourish your body at every stage of life. Innovative medical devices and health care solutions for cardiovascular health, diabetes management, diagnostic testing, nutrition, chronic pain and more. Explore Our Products Our vascular stents, catheters and guidewires, vessel closure devices and diagnostic and imaging tools make up our broad portfolio of innovative and minimally invasive products for the treatment of peripheral artery disease. Food and Drug Administration today approved the first fully absorbable stent to treat coronary artery disease. Dec 19, 2017 · Now, stents are used in nearly all coronary angioplasty procedures, and significantly reduce the likelihood of the artery becoming obstructed again. Epic Max aortic valves provide significant improvements to radiopacity and implantability, preserving more choices for long-term treatment paths. mrvsx wlbbk qmh qnrubkz dqzdpv whtbieq akmsnk irkcrs kra vphycjou bboe kwzezfr enwu ffnjv ucbacfh